Method of separating components in a biological fluid

Claim 2

A process for removing an adsorbable component from a biological fluid comprising contacting the fluid with a portion of insolubilized serum protein adsorbent capable of forming a finely dispersed, precipitable suspension for a time sufficient to adsorb the component.

Claim 3

A process according to claim 1 wherein the adsorbent is insolubilized serum albumin.

Claim 4

A process according to claim 2 wherein the insolubilized serum albumin is selected from the group consisting of macroaggregated serum albumin and polymerized serum albumin.

Claim 5

A process according to claim 1 wherein the particles sizes vary from near colloidal size up to about 100μ.

Claim 6

A process according to claim 4 wherein the particle sizes vary from about 1 to about 10μ.

Claim 7

A process according to claim 1 wherein the adsorbent is separated from the fluid after adsorption of the component.

Claim 8

A process according to claim 6 wherein separation from the fluid is by centrifuging to precipitate the adsorbent followed by decantation of the liquid.

Claim 9

A process according to claim 1 wherein the biological fluid is selected from human and non-human blood serum.

Claim 10

A process according to claim 3 wherein the polymerized albumin is a copolymer of serum albumin and a carbodiimide.

Claim 11

A process according to claim 9 wherein the carbodiimide is 1-cyclohexyl-3-(2-morpholinoethyl)-carbodiimide metho-p-toluene sulfonate.

Claim 12

A process according to claim 1 wherein the adsorbable component has a molecular weight up to about 20,000.

Claim 13

A process according to claim 1 wherein the adsorbable component has a molecular weight up to about 2,000.

Claim 14

A process according to claim 12 wherein the fluid is blood serum and the adsorbable component is thyroid hormone unbound to serum proteins.

Claim 15

A process according to claim 13 wherein the hormone is T 3 .

Claim 16

A process according to claim 13 wherein the hormone is T 4 .

Claim 17

In a radioassay process for determining the binding capacity of serum proteins for thyroid hormone wherein a known quantity of thyroid hormone labeled with a radioactive isotope is added to a serum sample to compete for binding sites on said serum proteins with the thyroid hormone in said sample, the improvement comprising admixing insolubilized serum albumin capable of forming a finely dispersed, precipitable suspension in said serum to adsorb unbound labeled and unlabeled thyroid hormone and separating said insolubilized albumin from said serum containing bound labeled and unlabeled thyroid hormone.

Claim 18

In a radioassay process for determining the binding capacity of serum proteins for thyroid hormone wherein a known quantity of thyroid hormone labeled with a radioactive isotope is added to a serum sample to compete for binding sites on said serum proteins with the thyroid hormone in said sample, the improvement comprising admixing insolubilized serum albumin capable of forming a finely dispersed, precipitable suspension in said serum to adsorb unbound labeled and unlabeled thyroid hormone and separating said insolubilized albumin from said serum containing bound labeled and unlabeled thyroid hormone.

Claim 19

A process according to claim 16 wherein the labeled thyroid hormone is T 3 .

Claim 20

A process according to claim 17 wherein the insolubilized serum protein is selected from the group consisting of macroaggregated serum albumin and polymerized serum albumin.

Claim 21

A process according to claim 18 wherein the particle size of the insolubilized serum albumin varies from near colloidal size up to about 100μ.

Claim 22

A process according to claim 19 wherein the particle sizes vary from about 1 to about 10μ.

Claim 23

A process according to claim 18 wherein the insolubilized albumin is separated from the serum by centrifuging to precipitate the albumin followed by decantation of the liquid.

Claim 24

A process according to claim 18 wherein the insolubilized serum albumin and labeled hormone are admixed before mixing with said serum sample.

Claim 25

A process according to claim 20 wherein the insolubilized albumin and labeled hormone are admixed in a barbital buffer.

Claim 26

A process for measuring T 4 in a serum sample comprising: (a) treating the sample to denature thyroid binding proteins leaving the T 4 in solution in said sample; (b) admixing the denatured serum with a known quantity of thyroid binding globulin (TBG) and a known quantity of T 4 labeled with a radioactive isotope. (c) contacting the admixture of denatured serum, TBG and labeled T 4 with a quantity of insolubilized serum albumin capable of forming a finely dispersed, precipitable suspension in said denature serum to adsorb labeled and unlabeled T 4 unbound to said TBG; (d) separating said insolubilized albumin from said serum; and (e) counting the radiation emitted by one of said serum or said insolubilized albumin.

Claim 27

A process for measuring T 4 in a serum sample comprising: (a) treating the sample to denature thyroid binding proteins leaving the T 4 in solution in said sample; (b) admixing the denatured serum with a known quantity of thyroid binding globulin (TBG) and a known quantity of T 4 labeled with a radioactive isotope. (c) contacting the admixture of denatured serum, TBG and labeled T 4 with a quantity of insolubilized serum albumin capable of forming a finely dispersed, precipitable suspension in said denature serum to adsorb labeled and unlabeled T 4 unbound to said TBG; (d) separating said insolubilized albumin from said serum; and (e) counting the radiation emitted by one of said serum or said insolubilized albumin.

Claim 28

A process according to claim 24 wherein the insolubilized serum albumin is selected from the group consisting of macroaggregated albumin and polymerized serum albumin.

Claim 29

A process according to claim 25 wherein the particle size of the insolubilized serum albumin varies from near colloidal size to about 100μ.

Claim 30

A process according to claim 26 wherein the particle sizes vary from about 1 to about 10μ.

Claim 31

A process according to claim 24 wherein the insolubilized serum albumin, labeled hormone and TBG are admixed prior to mixing with the denatured serum.

Claim 32

A process according to claim 28 wherein the insolubilized albumin, labeled hormone and TBG are admixed in a barbital buffer.